HS Icon Vaccines, human use in  Flag China

2019
Exports | Imports
: $113M | $858M, World Rnk 18 / 123
Flag Rnk 1986 / 4613 | World Rnk 5 / 215
Flag Rnk 234 / 4562

2018 - 2019
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $7.56M | $113M, Thailand |  Ireland

2019
ECONOMIC COMPLEXITY of China
: 1, Rnk 30 / 147

2019
PRODUCT COMPLEXITY  IN Vaccines, human use
: 0.49, Rnk 1020 / 2764

Exports: In 2019, China exported $113M in Vaccines, human use, making it the 18th largest exporter of Vaccines, human use in the world. At the same year, Vaccines, human use was the 1986th most exported product in China. The main destination of Vaccines, human use exports from China are: India ($24M), Thailand ($22M), Egypt ($10.7M), Belgium ($6.55M), and Saudi Arabia ($6.28M).

The fastest growing export markets for Vaccines, human use of China between 2018 and 2019 were Thailand ($7.56M), Belgium ($6.55M), and India ($5.84M).

Imports: In 2019, China imported $858M in Vaccines, human use, becoming the 5th largest importer of Vaccines, human use in the world. At the same year, Vaccines, human use was the 234th most imported product in China. China imports Vaccines, human use primarily from: France ($236M), United Kingdom ($207M), Ireland ($150M), Belgium ($123M), and Spain ($57.5M).

The fastest growing import markets in Vaccines, human use for China between 2018 and 2019 were Ireland ($113M), Belgium ($94.8M), and Spain ($50.3M).

Tariffs: In 2018, the average tariff for China in Vaccines, human use was 2.34%. The countries with the highest import tariffs for Vaccines, human use were Burkina Faso (Most Favoured Nation duty rate treatement, 3%), Botswana (Most Favoured Nation duty rate treatement, 3%), Cote d'Ivoire (Most Favoured Nation duty rate treatement, 3%), Cameroon (Most Favoured Nation duty rate treatement, 3%), and Democratic Republic of the Congo (Most Favoured Nation duty rate treatement, 3%).

Latest Trends (January 2021)

#permalink to section

Overview: In January 2021 China's Vaccines, human use exports accounted up to $325M and imports accounted up to $101M, resulting in a positive trade balance of $224M. Between January 2020 and January 2021 the exports of China's   Vaccines, human use have increased by $317M (3.99k%) from $7.94M to $325M, while imports decreased by $-128M (-56.1%) from $229M to $101M.

Destinations: In January 2021, Vaccines, human use were exported mostly to Indonesia ($120M), United Arab Emirates ($73.1M), Turkey ($53.2M), Chile ($43.9M), and Serbia ($14.6M), and were imported mostly from United States ($38.2M), France ($23M), Belgium ($21M), and Ireland ($18.5M).

Growth: In January 2021, the increase in Vaccines, human use's year-by-year exports was explained primarily by an increase in exports to Indonesia ($120M or 260k%), Egypt ($612k or 47.3%), and Bangladesh ($465k or 7.67k%). In January 2021, the decrease in Vaccines, human use's year-by-year imports was explained primarily by a decrease in imports from Ireland ($-81.5M or -81.5%), United States ($-26.2M or -40.7%), and France ($-16.1M or -41.1%).

Subnational Monthly Trade

#permalink to section
Time Scale
Flow
Value

EXPORT GROWTH (January 2020 - January 2021): $317M, (3.99k%)

IMPORT GROWTH (January 2020 - January 2021): $-128M, (-56.1%)

MAIN EXPORTER (January 2021): Beijing, $320M

MAIN DESTINATION (January 2021): Indonesia, $120M

This section shows Vaccines, human use's exports and imports data at subnational level for China. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, human use over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Historical Data

#permalink to section
Value

EXPORTS (2019): $113M

IMPORTS (2019): $858M

NET TRADE (2019): -$744M

In 2019, China exported $113M in Vaccines, human use. The main destinations of China exports on Vaccines, human use were India ($24M), Thailand ($22M), Egypt ($10.7M), Belgium ($6.55M), and Saudi Arabia ($6.28M).

In 2019, China imported $858M in Vaccines, human use, mainly from France ($236M), United Kingdom ($207M), Ireland ($150M), Belgium ($123M), and Spain ($57.5M).

Explore Visualizations

IN 2019, China HAD A POSITIVE NET TRADE IN Vaccines, human use WITH:

IN 2019, China HAD A NEGATIVE NET TRADE IN Vaccines, human use WITH:

Flow

THE FASTEST GROWING Vaccines, human use EXPORT MARKETS FOR China WERE (2018 - 2019):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, human use BY China WERE (2018 - 2019):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2018, China's main exporting competitors in Vaccines, human use were:

In 2018, China's main importing competitors in Vaccines, human use were:

Explore Visualizations

Tariffs by Country

#permalink to section

In 2018, the average tariff for China in Vaccines, human use was 2.34%.

The countries with the highest tariffs for Vaccines, human use in China were Burkina Faso (Most Favoured Nation duty rate treatement, 3%), Botswana (Most Favoured Nation duty rate treatement, 3%), Cote d'Ivoire (Most Favoured Nation duty rate treatement, 3%), Cameroon (Most Favoured Nation duty rate treatement, 3%), and Democratic Republic of the Congo (Most Favoured Nation duty rate treatement, 3%).